Black Diamond Therapeutics, Inc. Common Stock — Chart, Price & News (NASDAQ:BDTX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Market Capitalization 152.39 M
Employee 21
Founded 2014
CEO N/A
Website www.blackdiamondtherapeutics.com
Headquarter Massachusetts, United States
FIGI BBG00MS4Y0W9
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

152.39 M Market capitalization

Price to earnings ratio

6.23

Price to sales ratio

2

Nouvelles

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Stifel réitère sa recommandation d’achat sur l’action Black Diamond Therapeutics à 8$

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Black Diamond Therapeutic (NASDAQ:BDTX), EastGroup Properties (NYSE:EGP)